A detailed history of Manufacturers Life Insurance Company, The transactions in Moderna, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 3,073,934 shares of MRNA stock, worth $129 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
3,073,934
Previous 2,894,995 6.18%
Holding current value
$129 Million
Previous $344 Million 40.24%
% of portfolio
0.19%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $11.4 Million - $22.4 Million
178,939 Added 6.18%
3,073,934 $205 Million
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $59 Million - $97.2 Million
-583,417 Reduced 16.77%
2,894,995 $344 Million
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $5.51 Million - $7.45 Million
-64,555 Reduced 1.82%
3,478,412 $371 Million
Q4 2023

Feb 13, 2024

SELL
$69.51 - $104.43 $23.2 Million - $34.8 Million
-333,180 Reduced 8.6%
3,542,967 $352 Million
Q3 2023

Nov 15, 2023

BUY
$96.41 - $126.61 $163 Million - $214 Million
1,690,341 Added 77.33%
3,876,147 $400 Million
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $4.33 Million - $5.86 Million
-36,522 Reduced 1.64%
2,185,806 $266 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $12.3 Million - $17.8 Million
-90,355 Reduced 4.07%
2,131,973 $327 Million
Q4 2022

Aug 11, 2023

SELL
$118.38 - $210.04 $9.84 Million - $17.5 Million
-83,140 Reduced 3.61%
2,222,328 $399 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $6.83 Million - $12.1 Million
57,712 Added 2.67%
2,222,328 $399 Million
Q3 2022

Aug 11, 2023

SELL
$118.07 - $194.18 $4.82 Million - $7.92 Million
-40,807 Reduced 1.74%
2,305,468 $273 Million
Q3 2022

Nov 03, 2022

SELL
$118.07 - $194.18 $21.4 Million - $35.3 Million
-181,659 Reduced 7.74%
2,164,616 $256 Million
Q2 2022

Aug 11, 2023

SELL
$117.13 - $176.59 $1.43 Million - $2.15 Million
-12,191 Reduced 0.52%
2,346,275 $335 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $15.3 Million - $23.1 Million
130,820 Added 5.9%
2,346,275 $335 Million
Q1 2022

Aug 11, 2023

BUY
$126.46 - $235.05 $28.6 Million - $53.2 Million
226,493 Added 10.62%
2,358,466 $406 Million
Q1 2022

May 20, 2022

BUY
$126.46 - $235.05 $4.38 Million - $8.14 Million
34,636 Added 1.59%
2,215,455 $382 Million
Q4 2021

Feb 16, 2022

BUY
$225.82 - $368.51 $213 Million - $348 Million
943,271 Added 76.22%
2,180,819 $553 Million
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $23.2 Million - $50.7 Million
-104,570 Reduced 7.79%
1,237,548 $476 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $68 Million - $123 Million
523,735 Added 64.0%
1,342,118 $315 Million
Q1 2021

May 03, 2021

BUY
$109.18 - $185.98 $55.7 Million - $95 Million
510,602 Added 165.9%
818,383 $107 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $25.9 Million - $67 Million
-394,395 Reduced 56.17%
307,781 $32.2 Million
Q3 2020

Nov 09, 2020

SELL
$54.34 - $94.85 $2.28 Million - $3.98 Million
-41,925 Reduced 5.63%
702,176 $49.7 Million
Q2 2020

Aug 10, 2020

SELL
$29.67 - $80.0 $13 Million - $35 Million
-437,515 Reduced 37.03%
744,101 $46.2 Million
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $261,703 - $464,826
14,719 Added 1.26%
1,181,616 $35.4 Million
Q4 2019

Feb 14, 2020

SELL
$13.93 - $21.28 $640,584 - $978,582
-45,986 Reduced 3.79%
1,166,897 $22.8 Million
Q3 2019

Nov 12, 2019

SELL
$12.26 - $18.07 $307,971 - $453,918
-25,120 Reduced 2.03%
1,212,883 $19.3 Million
Q2 2019

Aug 14, 2019

BUY
$13.7 - $28.34 $10.2 Million - $21.2 Million
747,148 Added 152.21%
1,238,003 $18.1 Million
Q1 2019

May 13, 2019

BUY
$14.45 - $23.7 $1.35 Million - $2.21 Million
93,158 Added 23.42%
490,855 $9.99 Million
Q4 2018

Feb 14, 2019

BUY
$13.52 - $18.8 $5.38 Million - $7.48 Million
397,697 New
397,697 $6.07 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.